|
1
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu Y and Zhou BP: Snail: More than EMT.
Cell Adh Migr. 4:199–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barrallo-Gimeno A and Nieto MA: The Snail
genes as inducers of cell movement and survival: implications in
development and cancer. Development. 132:3151–3161. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang H, Wang HS, Zhou BH, Li CL, Zhang F,
Wang XF, Zhang G, Bu XZ, Cai SH and Du J: Epithelial-mesenchymal
transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated
stabilization of snail in colorectal cancer. PLoS One.
8:e566642013. View Article : Google Scholar
|
|
7
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nuti SV, Mor G, Li P and Yin G: TWIST and
ovarian cancer stem cells: implications for chemoresistance and
metastasis. Oncotarget. 5:7260–7271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wushou A, Hou J, Zhao YJ and Shao ZM:
Twist-1 up-regulation in carcinoma correlates to poor survival. Int
J Mol Sci. 15:21621–21630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C,
Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, et al: Up-regulation
of TWIST in prostate cancer and its implication as a therapeutic
target. Cancer Res. 65:5153–5162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Xie D, Li X, Wong YC, Xin D, Guan
XY, Chua CW, Leung SC, Na Y and Wang X: Significance of TWIST
expression and its association with E-cadherin in bladder cancer.
Hum Pathol. 38:598–606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar
|
|
15
|
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z,
Sethi S and Sarkar FH: Epithelial to mesenchymal transition is
mechanistically linked with stem cell signatures in prostate cancer
cells. PLoS One. 5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Zhang G, Zhang H, Zhang F, Zhou B,
Ning F, Wang HS, Cai SH and Du J: Acquisition of
epithelial-mesenchymal transition phenotype and cancer stem
cell-like properties in cisplatin-resistant lung cancer cells
through AKT/β-catenin/Snail signaling pathway. Eur J Pharmacol.
723:156–166. 2014. View Article : Google Scholar
|
|
17
|
Kim YH, Kim G, Kwon CI, Kim JW, Park PW
and Hahm KB: TWIST1 and SNAI1 as markers of poor prognosis in human
colorectal cancer are associated with the expression of ALDH1 and
TGF-β 1. Oncol Rep. 31:1380–1388. 2014.PubMed/NCBI
|
|
18
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
19
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014.PubMed/NCBI
|
|
20
|
Xue X and Liang XJ: Overcoming drug
efflux-based multidrug resistance in cancer with nanotechnology.
Chin J Cancer. 31:100–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Logullo AF, Nonogaki S, Pasini FS, Osório
CA, Soares FA and Brentani MM: Concomitant expression of
epithelial-mesenchymal transition biomarkers in breast ductal
carcinoma: Association with progression. Oncol Rep. 23:313–320.
2010.PubMed/NCBI
|
|
22
|
Xue CS, Plieth D, Venkov C, Xu C and
Neilson EG: The gatekeeper effect of epithelial-mesenchymal
transition regulates the frequency of breast cancer metastasis.
Cancer Res. 63:3386–3394. 2003.PubMed/NCBI
|
|
23
|
Sheehan KM, Gulmann C, Eichler GS,
Weinstein JN, Barrett HL, Kay EW, Conroy RM, Liotta LA and
Petricoin EF III: Signal pathway profiling of epithelial and
stromal compartments of colonic carcinoma reveals
epithelial-mesenchymal transition. Oncogene. 27:323–331. 2008.
View Article : Google Scholar
|
|
24
|
Jung HY and Yang J: Unraveling the TWIST
between EMT and cancer stemness. Cell Stem Cell. 16:1–2. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Galván JA, Helbling M, Koelzer VH, Tschan
MP, Berger MD, Hädrich M, Schnüriger B, Karamitopoulou E, Dawson H,
Inderbitzin D, et al: TWIST1 and TWIST2 promoter methylation and
protein expression in tumor stroma influence the
epithelial-mesenchymal transition-like tumor budding phenotype in
colorectal cancer. Oncotarget. 6:874–885. 2015. View Article : Google Scholar :
|
|
26
|
Fan YL, Zheng M, Tang YL and Liang XH: A
new perspective of vasculogenic mimicry: EMT and cancer stem cells
(Review). Oncol Lett. 6:1174–1180. 2013.PubMed/NCBI
|
|
27
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McCoy EL, Iwanaga R, Jedlicka P, Abbey NS,
Chodosh LA, Heichman KA, Welm AL and Ford HL: Six1 expands the
mouse mammary epithelial stem/progenitor cell pool and induces
mammary tumors that undergo epithelial-mesenchymal transition. J
Clin Invest. 119:2663–2677. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang AD, Fan F, Camp ER, van Buren G, Liu
W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arumugam T, Ramachandran V, Fournier KF,
Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey
DJ and Choi W: Epithelial to mesenchymal transition contributes to
drug resistance in pancreatic cancer. Cancer Res. 69:5820–5828.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD
and Wang LH: Twist transcriptionally up-regulates AKT2 in breast
cancer cells leading to increased migration, invasion, and
resistance to paclitaxel. Cancer Res. 67:1979–1987. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kajiyama H, Shibata K, Terauchi M,
Yamashita M, Ino K, Nawa A and Kikkawa F: Chemoresistance to
paclitaxel induces epithelial-mesenchymal transition and enhances
metastatic potential for epithelial ovarian carcinoma cells. Int J
Oncol. 31:277–283. 2007.PubMed/NCBI
|
|
34
|
Fukuda Y and Schuetz JD: ABC transporters
and their role in nucleoside and nucleotide drug resistance.
Biochem Pharmacol. 83:1073–1083. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsu DS, Lan HY, Huang CH, Tai SK, Chang
SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY, et al: Regulation
of excision repair cross-complementation group 1 by Snail
contributes to cisplatin resistance in head and neck cancer. Clin
Cancer Res. 16:4561–4571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saxena M, Stephens MA, Pathak H and
Rangarajan A: Transcription factors that mediate
epithelial-mesenchymal transition lead to multidrug resistance by
upregulating ABC transporterss. Cell Death Dis. 2:e1792011.
View Article : Google Scholar
|
|
38
|
Zorzos HS, Lazaris AC, Korkolopoulou PA,
Kavantzas NG, Tseleni-Balafouta S, Patsouris ES, Tsavaris NV and
Davaris PS: Multidrug resistance proteins and topoisomerase IIalpha
expression in colon cancer: association with metastatic potential.
Pathology. 35:315–318. 2003. View Article : Google Scholar : PubMed/NCBI
|
